Beruflich Dokumente
Kultur Dokumente
Group List:
Serial Name ID No.
01 Umma Asma Akter 21-064
02 Rakibul Islam Pappu 21-082
03 Md. Sunny 21-088
04 Md. Rakibul Islam 21-112
05 Md. Saifuddin Bhuiyanh 21-169
06 Muhammad Saiful Alam 21-201
07 Alongkar Islam 21-217
08 Atikur Rahman Sunny 21-270
These are the salient features that we would like to focus on in the preparation of the report:
I. Background of pharmaceuticals industry.
II. Industry size.
III. Growth and trends.
IV. Current environment.
V. Import and export.
VI. Industry segmentation.
VII. Problems and limitations.
VIII. Market shares:
Local market.
Foreign market.
IX. Porter’s five forces and SWOT analysis.
X. Research and development.
XI. Distribution channels.
XII. Potential risks.
XIII. Pricing of pharmaceuticals.
Pharmaceuticals companies have both the direct and indirect relationship with the financial companies.
From taking monetary assistance to production of the products and for the expansion of their business,
pharmaceuticals companies have to depend on the financials ones, who later impact the socio-economic
development of the country. Here are the following relationships that we would like to show in this
segment:
The development of pharmaceutical industry has direct consequences to improve our economy in many
ways. We are here focusing on some of the key factors which are directly related with the development
of the economy:
I. Macro factors:
II. GDP
III. Population
IV. Education
V. Employment
VI. Generic drugs opportunities.
VII. Workforce skills.
VIII. Potential approaches to improving quality of pharmaceuticals in Bangladesh.
IX. Spending on health and growth of consciousness
X. Relationship with technology.
XI. Current shocks
XII. Contributions of pharmaceuticals companies in social activities.
XIII. Potential market.
XIV. Existing law and regulations.
XV. Industry policies.